Ameren Corp Files 8-K Report

TL;DR

Ameren filed an 8-K, check for updates.

AI Summary

On August 7, 2025, Ameren Corporation filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific new financial figures or material events were detailed in the provided text excerpt.

Why It Matters

This filing signals that Ameren Corporation is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification without specific details of negative events or financial distress.

Key Numbers

• 1-14756 — Commission File Number (Identifies Ameren Corp's filing history with the SEC.)
• 43-1723446 — I.R.S. Employer Identification No. (Ameren Corp's tax identification number.)

Key Players & Entities

• AMEREN CORP (company) — Registrant
• Missouri (company) — State of incorporation
• 1901 Chouteau Avenue (company) — Principal executive offices address
• St. Louis (company) — City of principal executive offices

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value per share AEE New York St
• $1,250,000,000 — o the Sales Agreement, and increased by $1,250,000,000 the aggregate gross sales price authori
• $1,482,210,000 — an aggregate gross sales price of up to $1,482,210,000 remains available for issuance under th

Filing Documents

• tm2522550d2_8k.htm (8-K) — 31KB
• tm2522550d2_ex1.htm (EX-1) — 502KB
• tm2522550d2_ex5.htm (EX-5) — 10KB
• tm2522550d2_ex1imgsp101.jpg (GRAPHIC) — 33KB
• tm2522550d2_ex5img01.jpg (GRAPHIC) — 41KB
• tm2522550d2_ex5img02.jpg (GRAPHIC) — 14KB
• 0001104659-25-075230.txt ( ) — 918KB
• aee-20250807.xsd (EX-101.SCH) — 3KB
• aee-20250807_lab.xml (EX-101.LAB) — 33KB
• aee-20250807_pre.xml (EX-101.PRE) — 22KB
• tm2522550d2_8k_htm.xml (XML) — 3KB

01 Other Events

ITEM 8.01 Other Events. On August 7, 2025, Ameren Corporation (the "Company") entered into a First Amendment to Equity Distribution Sales Agreement, dated August 7, 2025 (the "First Amendment"), which amended the Equity Distribution Sales Agreement, dated May 12, 2021 (the "Original Sales Agreement", and as so amended by the First Amendment, the "Sales Agreement"), with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC and Wells Fargo Securities, LLC, as sales agents and as forward sellers (in such capacities as applicable, the "Agents" and the "Forward Sellers"), and Bank of America, N.A., Barclays Bank PLC, Goldman Sachs & Co. LLC, JPMorgan Chase Bank, National Association, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, MUFG Securities EMEA plc, Royal Bank of Canada and Wells Fargo Bank, National Association, as forward purchasers (the "Forward Purchasers"). The First Amendment, among other matters, amended the Original Sales Agreement to add an additional Agent and Forward Seller and an additional Forward Purchaser (the "Additional Forward Purchaser") as parties to the Sales Agreement, and increased by $1,250,000,000 the aggregate gross sales price authorized under the Company's equity distribution program (the "Program"), pursuant to which the Company, through the Agents or the Forward Sellers, may offer and sell from time to time shares of the Company's common stock, par value $0.01 per share (the "Common Stock"). After giving effect to such increase, Common Stock with an aggregate gross sales price of up to $1,482,210,000 remains available for issuance under the Program. The Company has no obligation to offer or sell any Common Stock under the Sales Agreement and may at any time suspend offers under the Sales Agreement. The Sales Agreement provides that, in addition to the issuance and sale of

01 Financial Statements and Exhibits

ITEM 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Title 1 First Amendment to Equity Distribution Sales Agreement, dated August 7, 2025, by and among the Company and Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC and Wells Fargo Securities, LLC, as sales agents and as forward sellers, and Bank of America, N.A., Barclays Bank PLC, Goldman Sachs & Co. LLC, JPMorgan Chase Bank, National Association, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, MUFG Securities EMEA plc, Royal Bank of Canada and Wells Fargo Bank, National Association, as forward purchasers (including form of master forward confirmation). 5 Opinion of Stephen C. Lee, Esq., Vice President, Interim General Counsel and Secretary of the Company, regarding the legality of the Common Stock (including consent). 104 Cover Page Interactive Data File (formatted as Inline XBRL) - 3 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMEREN CORPORATION (Registrant) By: /s/ Michael L. Moehn Name: Michael L. Moehn Title: Senior Executive Vice President andChief FinancialOfficer Date: August 7, 2025

View Full Filing

View this 8-K filing on SEC EDGAR